SIEN - シエントラ （Sientra Inc.） シエントラSIENのチャート
SIENの企業情報
| symbol | SIEN |
|---|---|
| 会社名 | Sientra Inc （シエントラ） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Industrial Specialties |
| 業種 | 医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care） |
| 概要 | 事業概要 シエントラ(Sientra Inc.)は医療美学会社である。主要製品は乳房拡張および乳房再建手順に使用するためのシリコーンゲル乳房インプラントであり、形状、大きさ、およびテクスチャーの190以上のバリエーションを提供する。同社は乳房インプラントおよび乳房組織エキスパンダー、または乳製品を外科医に販売する。乳房インプラントは、主に現金支払いベースで行われる選択手続きで使用される。TRUE Textureは、インプラントシェル上のテクスチャリングを提供する。そのテクスチャリングは、咬合、回転、嚢状拘縮の発生率を低減するように設計される。同社はまた、乳房組織エキスパンダー及びその他の美容・専門製品を提供する。同社は解剖学的に整形されたテクスチャ、円形のテクスチャおよび滑らかな丸いHSC +乳房インプラントを提供する。同社はまた、脇の下の汗と臭いを減らし、全ての色の毛髪を永久に減らすための装置であるmiraDryシステムを提供する。 シエントラは、米国の美容整形機器メ―カ―。主な製品は、シリコン製豊胸手術用インプラントの｢トゥル―・テクスチャ―｣、乳房組織を伸長させるための皮膚拡張器｢ACX｣、鼻や顎など顔面用インプラントの｢シリメド｣など。本社は、カリフォルニア州サンタバ―バラ。 Headquartered in Santa Barbara, California, Sientra is a medical aesthetics company uniquely focused on plastic surgeons. The Company offers a suite of products designed to make a difference in patients' lives by enhancing their body image, growing their self-esteem, and restoring their confidence. Sientra has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company's Breast Products Segment includes its Sientra round and shaped breast implants, the first fifth generation breast implants approved by the FDA for sale in the United States, its ground-breaking Allox2® breast tissue expander with patented dual-port and integral drain technology, and BIOCORNEUM®, the #1 performing, preferred and recommended scar gel of plastic surgeons(*). The Company's miraDry Segment, comprised of its miraDry® system, is approved for sale in over 56 international markets and is the only non-surgical, FDA-cleared device indicated for the permanent reduction of underarm sweat and hair and may also reduce odor. |
| 本社所在地 | 420 South Fairview Avenue Suite 200 Santa Barbara CA 93117 USA |
| 代表者氏名 | Jeffrey M. Nugent Jeffrey M. Nugent |
| 代表者役職名 | Chairman of the Board Chief Executive Officer 取締役会長兼最高経営責任者 |
| 電話番号 | +1 805-679-8838 |
| 設立年月日 | 37834 |
| 市場名 | NASDAQ National Market System |
| ipoyear | 2014年 |
| 従業員数 | 200人 |
| url | www.sientra.com |
| nasdaq_url | https://www.nasdaq.com/symbol/sien |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -63.09300 |
| 終値（lastsale） | 21.83 |
| 時価総額（marketcap） | 620575708.65 |
| 時価総額 | 時価総額（百万ドル） 633.08390 |
| 売上高 | 売上高（百万ドル） 53.11400 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 555.15990 |
| 当期純利益 | 当期純利益（百万ドル） -35.11300 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Sientra Inc revenues increased from $15.7M to $32.2M. Net loss increased 18% to $37.5M. Revenues reflect miraDry segment increase from $0K to $14.3M Breast Products segment increase of 15% to $18M. Higher net loss reflects Breast Products segment loss totaling $350K vs. income of $8.8M miraDry segment loss totaling $1.7M vs. income of $0K. |
SIENのテクニカル分析
SIENのニュース
Rumble, Braze rise; Virgin Orbit, Sientra fall 2023/03/31 20:19:42 WNYT
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Friday: Virgin Orbit Holdings Inc., down 14 cents to 20 cents. Richard Branson’s satellite launch company is letting go of almost its entire work force. Pineapple Energy Inc., up 16 cents to $1.59. The broadband network services company beat analysts’ fourth-quarter financial forecasts. BlackBerry Ltd., up 56 cents to $4.56. The cybersecurity software and services company beat analysts’ fourth-quarter earnings expectations. Adverum Biotechnologies Inc., unchanged at 72 cents. The gene therapy company gave investors an encouraging update on an eye condition treatment it’s developing. Sientra Inc., down 13 cents to $1.54. The breast implant maker reported disappointing fourth-quarter financial results. Braze Inc., up $2.97 to $34.57. The cloud-based software company beat analysts’ fourth-quarter financial forecasts. Rumble Inc., up 66 cents to $10 The online video platform reported strong fourth-quarter financial results.
Craig-Hallum maintains Sientra Inc at Buy 2023/03/31 12:49:37 Investing.com
https://www.investing.com/news/pro/sientra-inc-receives-investment-bank-analyst-rating-update-3046334
Sientra, Inc. (SIEN) Q4 2022 Earnings Call Transcript 2023/03/30 23:54:06 Seeking Alpha
Sientra, Inc. (NASDAQ:NASDAQ:SIEN) Q4 2022 Results Conference Call March 30, 2023 4:00 PM ETCompany ParticipantsOliver Bennett - General Counsel and Chief Compliance OfficerRon Menezes -…
Sientra GAAP EPS of -$2.35 misses by $1.01, revenue of $25.07M misses by $0.13M 2023/03/30 20:34:30 Seeking Alpha
Sientra press release (NASDAQ:SIEN): Q4 GAAP EPS of -$2.35 misses by $1.01.Revenue of $25.07M (+10.7% Y/Y) misses by $0.13M.
Sientra Reports Record Fourth Quarter and Full Year Revenues and Expands Total Addressable Market With New Product Launches 2023/03/30 20:02:00 GlobeNewswire
Continued 2+ year trend of consecutive record quarterly growth; fastest growing brand in the US breast market
Sientra Announces Preliminary Results from Clinical Study and The First Shipment of Viality Fat Transfer System 2023/03/01 13:32:00 Wallstreet:Online
Data Supports Enhanced Viability of Fat in Breast Augmentation and Reconstruction Using the Viality System IRVINE, Calif., March 01, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced that it has begun commercial shipping of its Viality with AuraClens fat transfer system.
7 Short-Squeeze Stocks to Buy Before They Soar 2023/01/30 19:24:37 InvestorPlace
As much as we may recognize that short sellers perform a valuable service for the equities market, the concept of targeting short-squeeze stocks to buy just to penalize the pessimists carries cathartic value. Fundamentally, market bears operate like great white sharks. As loathsome and fearsome as these creatures may be, they eliminate weak or sick animals, thus benefitting the broader ecology. Similarly, bearish traders identify publicly traded enterprises that supposedly have no business commanding the value they do . If proven right, the bears take down their targets, allowing retail investors to focus on truly viable names. Still, the concept of making money from other people’s failures seems morally wrong. As well, sharks eating “cute” animals disrupt our psyche. Thus, when bears lose out from short-squeeze stocks to buy, the bulls feel no remorse. If you belong in that camp – or simply want to make a quick buck – going contrarian against the bears might work. Provided you can handle the extreme risks involved, below are the short-squeeze stocks to buy.
Beware The High Valuation: Hycroft Mining Holding Corporation (NASDAQ:HYMC) Is in red zone, Sientra, Inc. (NASDAQ:SIEN) Is in red zone 2023/01/26 19:11:36 Stock Equity
(HYMC) Constructed a change of -3.01% (Loss, ↓) in a total of its share price and finished it’s trading at 0.60. Hycroft Mining Holding Corporation, belongs to Basic Materials sector and Gold industry. The … The post Beware The High Valuation: Hycroft Mining Holding Corporation (NASDAQ:HYMC) Is in red zone, Sientra, Inc. (NASDAQ:SIEN) Is in red zone appeared first on Stocks Equity .
Sientra''s board gives nod for 1-for-10 share split 2023/01/20 14:45:11 Seeking Alpha
Sientra (SIEN) on Friday said its board approved a 1-for-10 reverse stock split.The reverse stock split was effective at 4:00 p.m
Sientra Announces 1-for-10 Reverse Stock Split 2023/01/20 14:25:00 GlobeNewswire
IRVINE, Calif., Jan. 20, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced that its Board of Directors has approved a 1-for-10 reverse stock split of the Company’s issued and outstanding common stock (the “Reverse Stock Split”). The Reverse Stock Split was effective at 4:00 p.m. Eastern Time on January 19, 2023. The Company’s common stock is expected to begin trading on The Nasdaq Global Market on a split-adjusted basis on January 23, 2023.
Cosmetics Implants Market Global Outlook, Latest Industry Trends and Future Development| Key Players - Dentsply Sirona, Institut Straumann, Zimmer Holdings, Johnson & Johnson, GC Aesthetics Sientra 2021/07/08 06:42:39 OpenPR
The Recently Released Report by Research N Reports titled as Global Cosmetics Implants Market is a detailed analogy that gives the reader an insight into the intricacies of the various elements like the growth rate, and impact of the socio-economic conditions that
Cosmetic Implants Market 2021 Precise Outlook| Sientra, Inc., Allergan, Inc., Zimmer Holdings, Inc., GC Aesthetics 2021/06/29 13:59:00 OpenPR
Market Insights Reports presents the Global Cosmetic Implants Market research report that provides a detailed overview of major players, restraints, challenges, opportunities, current industry trends and strategies impacting the global market along with estimation and forecast of revenue. This report
Cosmetic Implants Market Giants Spending Is Going To Boom | Zimmer, Sientra, Danaher, 3M 2021/06/14 22:12:00 iCrowdNewswire
The latest study released on the Global Cosmetic Implants Market by AMA Research evaluates market size, trend, and forecast to 2026. The Cosmetic Implants market study covers significant research data []